NCT01376193View on ClinicalTrials.gov

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Migraine Disorders
Interventions
DRUG

Naratriptan

Collection of safety data

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01376193 - Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet | Biotech Hunter | Biotech Hunter